Location Laupheim,
Germany
Published on Monday, October 21, 2024
Benedikt von Braunmühl, our CEO, recently spoke to European Biotechnology about our company's development and future direction. The interview gives valuable insights into how we are empowering tomorrow's therapies today.
The interview has been published in the Autumn 2024 issue about CDMOs and CROs on pages 72-73. You can download the full interview as a PDF document here.
Corporate Spokesperson
Rentschler Biopharma SE
Dr. Latika Bhonsle-Deeng
Global Head of Communications